Advanced Technologies and Regenerative Medicine

Advanced Technologies and Regenerative Medicine is a Johnson & Johnson-affiliated R&D organization focused on regenerative medicine, implantable devices, and drug-biologic-device combination products. The entity appears to function primarily as an innovation and intellectual-property holding and development group rather than as a standalone commercial-stage biotech company. Publicly visible activity is concentrated in patents and older job postings describing work in areas such as umbilical cord tissue-derived cells, tissue engineering, renal implants, drug delivery, and implantable medical technologies. Based on available evidence, the organization is healthcare-related and active as a corporate entity, but there is no clear recent evidence of an independent clinical pipeline or marketed therapeutics under the ATRM name.